Área salud
Vol. 2. Issue. 3. (July – September 2022)
Área salud
Experience with erenumab: Data from real clinical practice
Introduction The development of monoclonal antibodies against calcitonin gene-related peptide has represented a revolution in the treatment of migraine. Erenumab was the first of these drugs to be available in clinical practice in our setting. […]
Área salud
Knowledge about ischaemic stroke in a school community in Bogota, Colombia
Introduction The benefit of preventive measures and of acute treatment for ischaemic stroke relies on knowledge of the disease among the general population. The aim of this study was to evaluate the knowledge of ischaemic […]
Área salud
Genetic characterization of Limb Girdle Muscular Dystrophies and Pompe Disease in a large Argentine cohort
Introduction The Limb Girdle Muscular Dystrophies (LGMD) are a heterogeneous group of genetically inherited myopathies characterized by progressive weakness of the limb-girdle muscles. Pompe disease (PD) is a treatable lysosomal storage disorder with overlapping clinical […]
Área salud
Real-world data on the effectiveness and safety of teriflunomide in patients with relapsing–remitting multiple sclerosis: The EFFECT study
Introduction The objective of the present study was to evaluate the effectiveness and safety of teriflunomide in relapsing–remitting multiple sclerosis (RRMS) patients treated in a real-world setting. Methods This retrospective study was conducted at neurology […]